Medworxx
Solutions Inc. ("Medworxx") (TSX VENTURE: MWX)
today is pleased to issue the Q2/2014 market update for the Medworxx
Patient Throughput Review (“PTR”) program. Since its introduction in
2013, the PTR has been widely accepted by hospitals and health systems
internationally. The PTR methodology leverages the Medworxx Clinical
Criteria Module software to unlock unique patient flow information
to help organizations understand the scope of their patient flow issues
and identify specific opportunities to improve quality and performance.
Management consulting companies, Medworxx clinical consultants and
hospital process improvement groups are able to use the Medworxx
Clinical Criteria Module to rapidly identify patient flow data,
providing visibility into patient flow issues in the hospitals that they
provide services to. Consulting companies and hospital process
improvement groups are able to license the Medworxx software to deliver
PTRs independent of Medworxx.
Since the Q1/2014 market update issued April 30, 2014, seven additional
PTRs have been successfully delivered in Canada (2), the United Kingdom
(4) and the United States (1). This brings the total number of PTRs
completed to date to 32. PTRs have been completed in five countries to
date; Australia, Canada, France, the UK and the US. Medworxx and their
consulting partners are working with each site to analyze PTR data to
support strategic decision making and improve performance and quality
outcomes. “Our recent PTR with Medworxx provided us with the data needed
to identify and analyze patient throughput delays and recommend
strategies for performance improvement,” Stefani Daniels, Managing
Partner, Phoenix Medical Management, USA.
Sunnybrook Health Sciences Centre in Ontario, Canada, recently completed
a PTR, supported by Medworxx Clinical Consultants, to assess current
patient flow performance at the hospital. “The PTR was extremely
comprehensive and the findings were very helpful in identifying areas
for improvement, complete with actionable recommendations. The PTR
delivered valuable data that would otherwise be out of reach for us,”
stated Malcolm Moffat, EVP Programs, Sunnybrook Health Sciences Centre.
“We are excited to see PTR related activity continue in the regions we
are actively marketing into. In the last two quarters we have completed
PTR engagements in the US, Canada, France and the UK both independently
and together with consulting partners. We continue to believe that the
PTR will provide hospitals with the benchmark analysis needed to build a
business case in order take steps to embed our Clinical Criteria Module
for real-time operational use,” said Dan Matlow, CEO and President,
Medworxx.
About Medworxx
Medworxx delivers health information technology solutions to over 350
hospitals internationally. Medworxx helps hospitals meet patient flow
challenges, and requirements in compliance and education. Medworxx
Clinical Criteria – flagship of Medworxx Patient Flow that includes
electronic bed board and independent assessment components – currently
serves 34% of the acute care beds in Canada. Founded in 2004, Medworxx
is based in Toronto, ON, and publicly traded on the TSX Venture
Exchange: MWX.
For more information visit: http://www.medworxx.com.
Disclaimer
The statements made in this press release may contain forward-looking
statements that may involve a number of risks and uncertainties. Actual
events or results could differ materially from the company’s
expectations and projections. The TSX Venture Exchange has not reviewed
this press release and neither approved nor disapproved the information
contained in this press release.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20140819005059r1&sid=ntxv4&distro=nx&lang=en)
Copyright Business Wire 2014